Table 1.
Co-infection cases of respiratory viruses in subjects among different groups.
| Virus co-detection status | Total | Age groups |
Gender |
Underlying diseases |
||||
|---|---|---|---|---|---|---|---|---|
| ≤18 years | 19–50 years | ≥50 years | Male | Female | Yes | No | ||
| n = 6 | n = 10 | n = 15 | n = 17 | n = 14 | n = 21 | n = 10 | ||
| ADVs + RSVs | 5 | 1 | 1 | 3 | 3 | 2 | 2 | 3 |
| ADVs + IFVB | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| ADVs + EVs | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
| ADVs + HRVs | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
| ADVs + PIVs | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| IFVA + ADVs | 4 | 1 | 1 | 2 | 2 | 2 | 3 | 1 |
| IFVA + HRVs | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| IFVA + HCoVs | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| IFVA + PIVs | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| RSVs + HRVs | 2 | 0 | 1 | 1 | 2 | 0 | 1 | 0 |
| RSVs + HMPV | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| RSVs + EVs | 1 | 0 | 1 | 0 | 0 | 1 | 2 | 0 |
| PIVs + HRVs | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 1 |
| PIVs + HCoVs | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| PIVs + RSVs | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
| HMPV + HCoVs | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| HMPV + HRVs | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
| ADVs + IFVA + RSVs | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| ADVs + EVs + HRVs | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
| ADVs + RSVs + EVs | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| IFVA + IFVB + EVs | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
ADVs, adenoviruses; EVs, enteroviruses; HCoVs, human coronaviruses; HMPV, human metapneumovirus; HRVs, human rhinoviruses; IFVA, influenza A virus; IFVB, influenza B virus; PIVs, parainfluenza viruses; RSVs, respiratory syncytial viruses.